Filing Details
- Accession Number:
- 0001562180-24-006885
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-20 16:00:59
- Reporting Period:
- 2024-09-18
- Accepted Time:
- 2024-09-20 16:00:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1822462 | Foghorn Therapeutics Inc. | FHTX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1939167 | Carlos Costa | 500 Technology Square Ste #700 Cambridge MA 02139 | Chief People Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-09-18 | 11,574 | $3.72 | 11,574 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-09-18 | 11,574 | $10.05 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2024-09-18 | 11,574 | $0.00 | 11,574 | $3.72 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
76,402 | 2029-02-12 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024.
- The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.25 per share.
- The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested.